The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Thyroid Cancer Testing-Global Market Insights and Sales Trends 2024
Synopsis
Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones.
The global Thyroid Cancer Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Thyroid Cancer Testing in various end use industries. The expanding demands from the Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers and Cancer Research Institutes, are propelling Thyroid Cancer Testing market. Imaging Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blood Tests segment is estimated at % CAGR for the next seven-year period.
The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technological advancements are expected to boost the market of thyroid cancer testing.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thyroid Cancer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thyroid Cancer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thyroid Cancer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thyroid Cancer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thyroid Cancer Testing covered in this report include Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Siemens, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips and Canon Medical Systems, etc.
The global Thyroid Cancer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
F. Hoffmann-La Roche
Thermo Fisher Scientific
Siemens
Bio Rad Laboratories
GE Healthcare
Illumina
Koninklijke Philips
Canon Medical Systems
Agilent Technologies
Global Thyroid Cancer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thyroid Cancer Testing market, Segment by Type:
Imaging Tests
Blood Tests
Biopsy Tests
Other
Global Thyroid Cancer Testing market, by Application
Hospital Associated Labs
Independent Diagnostic Labs
Diagnostic Imaging Centers
Cancer Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thyroid Cancer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones.
The global Thyroid Cancer Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Thyroid Cancer Testing in various end use industries. The expanding demands from the Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers and Cancer Research Institutes, are propelling Thyroid Cancer Testing market. Imaging Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blood Tests segment is estimated at % CAGR for the next seven-year period.
The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technological advancements are expected to boost the market of thyroid cancer testing.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thyroid Cancer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thyroid Cancer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thyroid Cancer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thyroid Cancer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thyroid Cancer Testing covered in this report include Abbott Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Siemens, Bio Rad Laboratories, GE Healthcare, Illumina, Koninklijke Philips and Canon Medical Systems, etc.
The global Thyroid Cancer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
F. Hoffmann-La Roche
Thermo Fisher Scientific
Siemens
Bio Rad Laboratories
GE Healthcare
Illumina
Koninklijke Philips
Canon Medical Systems
Agilent Technologies
Global Thyroid Cancer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thyroid Cancer Testing market, Segment by Type:
Imaging Tests
Blood Tests
Biopsy Tests
Other
Global Thyroid Cancer Testing market, by Application
Hospital Associated Labs
Independent Diagnostic Labs
Diagnostic Imaging Centers
Cancer Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thyroid Cancer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Thyroid Cancer Testing
1.1 Thyroid Cancer Testing Market Overview
1.1.1 Thyroid Cancer Testing Product Scope
1.1.2 Thyroid Cancer Testing Market Status and Outlook
1.2 Global Thyroid Cancer Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Thyroid Cancer Testing Market Size by Region (2018-2029)
1.4 Global Thyroid Cancer Testing Historic Market Size by Region (2018-2023)
1.5 Global Thyroid Cancer Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Thyroid Cancer Testing Market Size (2018-2029)
1.6.1 North America Thyroid Cancer Testing Market Size (2018-2029)
1.6.2 Europe Thyroid Cancer Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Thyroid Cancer Testing Market Size (2018-2029)
1.6.4 Latin America Thyroid Cancer Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Thyroid Cancer Testing Market Size (2018-2029)
2 Thyroid Cancer Testing Market by Type
2.1 Introduction
2.1.1 Imaging Tests
2.1.2 Blood Tests
2.1.3 Biopsy Tests
2.1.4 Other
2.2 Global Thyroid Cancer Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Thyroid Cancer Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Thyroid Cancer Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Thyroid Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Thyroid Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Thyroid Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Thyroid Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Thyroid Cancer Testing Revenue Breakdown by Type (2018-2029)
3 Thyroid Cancer Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospital Associated Labs
3.1.2 Independent Diagnostic Labs
3.1.3 Diagnostic Imaging Centers
3.1.4 Cancer Research Institutes
3.1.5 Others
3.2 Global Thyroid Cancer Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Thyroid Cancer Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Thyroid Cancer Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Thyroid Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Thyroid Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Thyroid Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Thyroid Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Thyroid Cancer Testing Revenue Breakdown by Application (2018-2029)
4 Thyroid Cancer Testing Competition Analysis by Players
4.1 Global Thyroid Cancer Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thyroid Cancer Testing as of 2022)
4.3 Date of Key Players Enter into Thyroid Cancer Testing Market
4.4 Global Top Players Thyroid Cancer Testing Headquarters and Area Served
4.5 Key Players Thyroid Cancer Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Thyroid Cancer Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Thyroid Cancer Testing Products, Services and Solutions
5.1.4 Abbott Laboratories Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Thyroid Cancer Testing Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Thyroid Cancer Testing Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Recent Developments
5.4 Siemens
5.4.1 Siemens Profile
5.4.2 Siemens Main Business
5.4.3 Siemens Thyroid Cancer Testing Products, Services and Solutions
5.4.4 Siemens Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Recent Developments
5.5 Bio Rad Laboratories
5.5.1 Bio Rad Laboratories Profile
5.5.2 Bio Rad Laboratories Main Business
5.5.3 Bio Rad Laboratories Thyroid Cancer Testing Products, Services and Solutions
5.5.4 Bio Rad Laboratories Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Bio Rad Laboratories Recent Developments
5.6 GE Healthcare
5.6.1 GE Healthcare Profile
5.6.2 GE Healthcare Main Business
5.6.3 GE Healthcare Thyroid Cancer Testing Products, Services and Solutions
5.6.4 GE Healthcare Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.6.5 GE Healthcare Recent Developments
5.7 Illumina
5.7.1 Illumina Profile
5.7.2 Illumina Main Business
5.7.3 Illumina Thyroid Cancer Testing Products, Services and Solutions
5.7.4 Illumina Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Illumina Recent Developments
5.8 Koninklijke Philips
5.8.1 Koninklijke Philips Profile
5.8.2 Koninklijke Philips Main Business
5.8.3 Koninklijke Philips Thyroid Cancer Testing Products, Services and Solutions
5.8.4 Koninklijke Philips Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Koninklijke Philips Recent Developments
5.9 Canon Medical Systems
5.9.1 Canon Medical Systems Profile
5.9.2 Canon Medical Systems Main Business
5.9.3 Canon Medical Systems Thyroid Cancer Testing Products, Services and Solutions
5.9.4 Canon Medical Systems Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Canon Medical Systems Recent Developments
5.10 Agilent Technologies
5.10.1 Agilent Technologies Profile
5.10.2 Agilent Technologies Main Business
5.10.3 Agilent Technologies Thyroid Cancer Testing Products, Services and Solutions
5.10.4 Agilent Technologies Thyroid Cancer Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Agilent Technologies Recent Developments
6 North America
6.1 North America Thyroid Cancer Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Thyroid Cancer Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Cancer Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Thyroid Cancer Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Cancer Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Thyroid Cancer Testing Market Dynamics
11.1 Thyroid Cancer Testing Industry Trends
11.2 Thyroid Cancer Testing Market Drivers
11.3 Thyroid Cancer Testing Market Challenges
11.4 Thyroid Cancer Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
